P14.19 Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions

Title
P14.19 Preclinical and clinical efficacy of entrectinib in primary and metastatic brain tumors harboring NTRK, ROS1, or ALK gene fusions
Authors
Keywords
-
Journal
NEURO-ONCOLOGY
Volume 19, Issue suppl_3, Pages iii106-iii106
Publisher
Oxford University Press (OUP)
Online
2017-04-27
DOI
10.1093/neuonc/nox036.404

Ask authors/readers for more resources

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Create your own webinar

Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.

Create Now